Xavier Filella

12.0k total citations
242 papers, 9.2k citations indexed

About

Xavier Filella is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Xavier Filella has authored 242 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Pulmonary and Respiratory Medicine, 78 papers in Oncology and 56 papers in Molecular Biology. Recurrent topics in Xavier Filella's work include Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Glycosylation and Glycoproteins Research (19 papers). Xavier Filella is often cited by papers focused on Prostate Cancer Treatment and Research (44 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Glycosylation and Glycoproteins Research (19 papers). Xavier Filella collaborates with scholars based in Spain, United States and France. Xavier Filella's co-authors include Rafael Molina, Laura Foj, Antonio M. Ballesta, Antoní Torres, Jaume Pahisa, José Miguel Escudero Fernández, Núria Giménez, Josep M. Augé, José Maria Augé and A M Ballesta and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Xavier Filella

236 papers receiving 8.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xavier Filella Spain 56 2.7k 2.7k 2.4k 2.1k 1.2k 242 9.2k
Gaetano De Rosa Italy 46 1.4k 0.5× 3.0k 1.1× 2.7k 1.1× 1.5k 0.7× 1.4k 1.1× 349 8.9k
Martin H. Cohen United States 53 3.5k 1.3× 5.4k 2.0× 3.7k 1.6× 1.9k 0.9× 926 0.8× 160 12.5k
Luan D. Truong United States 58 3.6k 1.3× 1.6k 0.6× 4.3k 1.8× 937 0.4× 2.3k 1.9× 288 11.9k
Patrick A. Burch United States 38 4.3k 1.6× 2.7k 1.0× 1.5k 0.6× 766 0.4× 1.1k 0.9× 86 7.6k
David Chia United States 45 1.5k 0.6× 1.6k 0.6× 3.7k 1.5× 783 0.4× 1.7k 1.4× 146 9.0k
Karl‐Walter Jauch Germany 58 2.1k 0.8× 4.2k 1.6× 3.0k 1.2× 1.3k 0.6× 3.7k 3.0× 229 11.4k
Fiorella Calabrese Italy 45 2.0k 0.7× 1.6k 0.6× 1.6k 0.7× 1.4k 0.6× 1.2k 1.0× 292 8.4k
Markus Raderer Austria 56 2.7k 1.0× 6.0k 2.3× 1.2k 0.5× 2.4k 1.1× 2.4k 1.9× 324 11.9k
Alexandar Tzankov Switzerland 56 2.1k 0.8× 5.0k 1.9× 3.6k 1.5× 1.0k 0.5× 1.3k 1.1× 379 16.0k
Muhammad Wasif Saif United States 44 1.4k 0.5× 4.6k 1.7× 1.9k 0.8× 995 0.5× 1.2k 1.0× 412 7.9k

Countries citing papers authored by Xavier Filella

Since Specialization
Citations

This map shows the geographic impact of Xavier Filella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Filella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Filella more than expected).

Fields of papers citing papers by Xavier Filella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Filella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Filella. The network helps show where Xavier Filella may publish in the future.

Co-authorship network of co-authors of Xavier Filella

This figure shows the co-authorship network connecting the top 25 collaborators of Xavier Filella. A scholar is included among the top collaborators of Xavier Filella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xavier Filella. Xavier Filella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Trapé, Jaume, et al.. (2024). Factors influencing blood tumor marker concentrations in the absence of neoplasia. Tumor Biology. 46(s1). S35–S63. 3 indexed citations
2.
Filella, Xavier, Álvaro González, Josep M. Augé, et al.. (2023). Una nueva perspectiva en el cribado del cáncer de próstata. SHILAP Revista de lepidopterología. 4(3). 212–217.
3.
Filella, Xavier, Álvaro González, Josep M. Augé, et al.. (2023). A new approach to prostate cancer screening. SHILAP Revista de lepidopterología. 4(3). 207–211. 2 indexed citations
4.
Parra‐Robert, Marina, et al.. (2018). Relationship Between CA 19.9 and the Lewis Phenotype: Options to Improve Diagnostic Efficiency. Anticancer Research. 38(10). 5883–5888. 46 indexed citations
5.
Molina, Rafael, Ramón M. Marrades, Josep M. Augé, et al.. (2015). Assessment of a Combined Panel of Six Serum Tumor Markers for Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 193(4). 427–437. 131 indexed citations
6.
Foj, Laura, Xavier Filella, J Alcover, et al.. (2013). Variability of assay methods for total and free PSA after WHO standardization. Tumor Biology. 35(3). 1867–1873. 18 indexed citations
7.
Cobo, Teresa, Montse Palacio, Aleix Navarro‐Sastre, et al.. (2011). Clinical and inflammatory markers in amniotic fluid as predictors of adverse outcomes in preterm premature rupture of membranes. American Journal of Obstetrics and Gynecology. 205(2). 126.e1–126.e8. 63 indexed citations
8.
Molina, Rafael, José Maria Augé, José Miguel Escudero Fernández, et al.. (2010). Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value. Tumor Biology. 31(3). 171–180. 61 indexed citations
9.
10.
Filella, Xavier. (2007). Els marcadors tumorals: què són i per a què serveixen. 8.
11.
Rabinovich, Roberto, Esther Ardite, Neus Carbó, et al.. (2003). Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients. European Respiratory Journal. 21(5). 789–794. 124 indexed citations
12.
Molina, Rafael, Xavier Filella, Gabriel Zanón, et al.. (2003). Prospective evaluation of tumor markers (c-erbB-2 oncoprotein, CEA and CA 15.3) in patients with locoregional breast cancer.. PubMed. 23(2A). 1043–50. 40 indexed citations
13.
Molina, Rafael, Xavier Filella, Rafael Fuentes, et al.. (2003). Tumor Markers (CEA, CA 125, CYFRA 21-1, SCC and NSE) in Patients with Non-Small Cell Lung Cancer as an Aid in Histological Diagnosis and Prognosis. Tumor Biology. 24(4). 209–218. 232 indexed citations
14.
Filella, Xavier, et al.. (2002). Formación continuada del médico práctico: estructura y función de las citocinas. Medicina integral: Medicina preventiva y asistencial en atención primaria de la salud. 39(2). 63–71. 3 indexed citations
15.
16.
Angrill, J., et al.. (2001). Bronchial Inflammation and Colonization in Patients with Clinically Stable Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 164(9). 1628–1632. 200 indexed citations
17.
Filella, Xavier, et al.. (2000). Usefulness of urinary nuclear matrix protein 22 (NMP22) as a marker for transitional cell carcinoma of the bladder.. PubMed. 20(2B). 1169–72. 14 indexed citations
18.
Filella, Xavier, J Alcover, Rafael Molina, et al.. (1997). Clinical evaluation of free PSA/Total PSA (Prostate-specific Antigen) ratio in the diagnosis of prostate cancer. European Journal of Cancer. 33(8). 1226–1229. 16 indexed citations
19.
Molina, Rafael, Judith Jo, Xavier Filella, et al.. (1996). C-erbB-2 oncoprotein in the sera and tissue of patients with breast cancer. Utility in prognosis.. PubMed. 16(4B). 2295–300. 42 indexed citations
20.
Molina, Rafael, et al.. (1995). Prognostic value of TPS in patients with head and neck malignancies: comparison with SCC.. PubMed. 15(2). 479–84. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaetano De Rosa Breakdown of academic impact, for papers by Martin H. Cohen Breakdown of academic impact, for papers by Luan D. Truong Breakdown of academic impact, for papers by Patrick A. Burch Breakdown of academic impact, for papers by David Chia Breakdown of academic impact, for papers by Karl‐Walter Jauch Breakdown of academic impact, for papers by Fiorella Calabrese Breakdown of academic impact, for papers by Markus Raderer Breakdown of academic impact, for papers by Alexandar Tzankov Breakdown of academic impact, for papers by Muhammad Wasif Saif
Rankless by CCL
2026